Literature DB >> 19454684

Generation of T cells from human embryonic stem cell-derived hematopoietic zones.

Frank Timmermans1, Imke Velghe, Lieve Vanwalleghem, Magda De Smedt, Stefanie Van Coppernolle, Tom Taghon, Harry D Moore, Georges Leclercq, Anton W Langerak, Tessa Kerre, Jean Plum, Bart Vandekerckhove.   

Abstract

Human embryonic stem cells (hESC) are pluripotent stem cells. A major challenge in the field of hESC is the establishment of specific differentiation protocols that drives hESC down a particular lineage fate. So far, attempts to generate T cells from hESC in vitro were unsuccessful. In this study, we show that T cells can be generated in vitro from hESC-derived hematopoietic precursor cells present in hematopoietic zones (HZs). These zones are morphologically similar to blood islands during embryonic development, and are formed when hESC are cultured on OP9 stromal cells. Upon subsequent transfer of these HZs on OP9 cells expressing high levels of Delta-like 1 and in the presence of growth factors, cells expand and differentiate to T cells. Furthermore, we show that T cells derive exclusively from a CD34(high)CD43(low) population, further substantiating the notion that hESC-derived CD34(high)CD43(low) cells are formed in HZs and are the only population containing multipotent hematopoietic precursor cells. Differentiation to T cells sequentially passes through the physiological intermediates: CD34(+)CD7(+) T/NK committed, CD7(+)CD4(+)CD8(-) immature single positive, CD4(+)CD8(+) double positive, and finally CD3(+)CD1(-)CD27(+) mature T cell stages. TCRalphabeta(+) and TCRgammadelta(+) T cells are generated. Mature T cells are polyclonal, proliferate, and secrete cytokines in response to mitogens. This protocol for the de novo generation of T cells from hESC could be clinically and scientifically relevant.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19454684     DOI: 10.4049/jimmunol.0803670

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  88 in total

Review 1.  Hematopoiesis from pluripotent stem cell lines.

Authors:  Hiroshi Sakamoto; Kiyomi Tsuji-Tamura; Minetaro Ogawa
Journal:  Int J Hematol       Date:  2010-02-20       Impact factor: 2.490

2.  Generation of mature blood cells from pluripotent stem cells.

Authors:  Igor I Slukvin
Journal:  Haematologica       Date:  2010-10       Impact factor: 9.941

Review 3.  Generation of mature hematopoietic cells from human pluripotent stem cells.

Authors:  Padma Priya Togarrati; Kran Suknuntha
Journal:  Int J Hematol       Date:  2012-05-31       Impact factor: 2.490

Review 4.  Generation of red blood cells from human embryonic/induced pluripotent stem cells for blood transfusion.

Authors:  Yasuhiro Ebihara; Feng Ma; Kohichiro Tsuji
Journal:  Int J Hematol       Date:  2012-05-31       Impact factor: 2.490

Review 5.  Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.

Authors:  Igor I Slukvin
Journal:  Blood       Date:  2013-10-11       Impact factor: 22.113

6.  NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells.

Authors:  Akhilesh Kumar; Jeong Hee Lee; Kran Suknuntha; Saritha S D'Souza; Abir S Thakur; Igor I Slukvin
Journal:  J Immunol       Date:  2018-12-21       Impact factor: 5.422

7.  Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells.

Authors:  Kyung-Dal Choi; Maxim Vodyanik; Igor I Slukvin
Journal:  Nat Protoc       Date:  2011-02-17       Impact factor: 13.491

Review 8.  New cell sources for T cell engineering and adoptive immunotherapy.

Authors:  Maria Themeli; Isabelle Rivière; Michel Sadelain
Journal:  Cell Stem Cell       Date:  2015-04-02       Impact factor: 24.633

Review 9.  De novo generation of HSCs from somatic and pluripotent stem cell sources.

Authors:  Linda T Vo; George Q Daley
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

Review 10.  The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies.

Authors:  Katja G Weinacht; Patrick M Brauer; Kerstin Felgentreff; Alex Devine; Andrew R Gennery; Silvia Giliani; Waleed Al-Herz; Axel Schambach; Juan Carlos Zúñiga-Pflücker; Luigi D Notarangelo
Journal:  Curr Opin Immunol       Date:  2012-07-25       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.